<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>68(2)</volume><submitter>Borges FK</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Timing to surgery for acute cholecystitis remains variable, ranging from early (&lt; 7 d) to delayed surgery (> 7 d). Accelerated surgery may result in better outcomes owing to reduced exposure to hypercoagulable and inflammatory states. We sought to determine the feasibility of a trial comparing accelerated surgery with standard care among patients with calculous acute cholecystitis.&lt;h4>Methods&lt;/h4>We conducted a multicentre pilot randomized controlled trial. We randomly assigned adult patients with acute cholecystitis to receive accelerated surgery (i.e., goal of surgery within 6 hours of diagnosis) or standard care. The primary feasibility outcome included recruitment of 60 patients, randomly assigning the equivalent of 1 patient per site per month, and 95% follow-up at 90 days.&lt;h4>Results&lt;/h4>Sixty patients (mean age 61.7, standard deviation [SD] 13.5, yr; 27 [45%] female) were randomly assigned to accelerated surgery (&lt;i>n&lt;/i> = 31) or standard care (&lt;i>n&lt;/i> = 29) from December 2019 to December 2021, with 2 recruitment pauses due to the COVID-19 pandemic. The median time from diagnosis to surgery was 5.8 (interquartile range [IQR] 4.4-11.1) hours in the accelerated care arm and 20.3 (IQR 6.8-26.8) hours in the standard care arm. Across 4 sites, 4.6 patients per month were randomly assigned. All patients completed the 90-day follow up.&lt;h4>Conclusion&lt;/h4>In our pilot trial, we found that accelerated cholecystectomy was achievable. These results show the feasibility of a trial comparing accelerated and standard care among patients requiring surgery for acute cholecystitis and support a definitive trial.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov, no. NCT04033822.</pubmed_abstract><journal>Canadian journal of surgery. Journal canadien de chirurgie</journal><pagination>E122-E131</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11999720</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Fast Track Pathway to Accelerated Cholecystectomy Versus Standard of Care for Acute Cholecystitis (FAST) pilot trial.</pubmed_title><pmcid>PMC11999720</pmcid><pubmed_authors>Borges FK</pubmed_authors><pubmed_authors>Di Sante E</pubmed_authors><pubmed_authors>Nenshi R</pubmed_authors><pubmed_authors>Park LJ</pubmed_authors><pubmed_authors>Devereaux PJ</pubmed_authors><pubmed_authors>Vincent J</pubmed_authors><pubmed_authors>Tsiplova K</pubmed_authors><pubmed_authors>Serrano PE</pubmed_authors><pubmed_authors>Vogt K</pubmed_authors><pubmed_authors>Engels P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fast Track Pathway to Accelerated Cholecystectomy Versus Standard of Care for Acute Cholecystitis (FAST) pilot trial.</name><description>&lt;h4>Background&lt;/h4>Timing to surgery for acute cholecystitis remains variable, ranging from early (&lt; 7 d) to delayed surgery (> 7 d). Accelerated surgery may result in better outcomes owing to reduced exposure to hypercoagulable and inflammatory states. We sought to determine the feasibility of a trial comparing accelerated surgery with standard care among patients with calculous acute cholecystitis.&lt;h4>Methods&lt;/h4>We conducted a multicentre pilot randomized controlled trial. We randomly assigned adult patients with acute cholecystitis to receive accelerated surgery (i.e., goal of surgery within 6 hours of diagnosis) or standard care. The primary feasibility outcome included recruitment of 60 patients, randomly assigning the equivalent of 1 patient per site per month, and 95% follow-up at 90 days.&lt;h4>Results&lt;/h4>Sixty patients (mean age 61.7, standard deviation [SD] 13.5, yr; 27 [45%] female) were randomly assigned to accelerated surgery (&lt;i>n&lt;/i> = 31) or standard care (&lt;i>n&lt;/i> = 29) from December 2019 to December 2021, with 2 recruitment pauses due to the COVID-19 pandemic. The median time from diagnosis to surgery was 5.8 (interquartile range [IQR] 4.4-11.1) hours in the accelerated care arm and 20.3 (IQR 6.8-26.8) hours in the standard care arm. Across 4 sites, 4.6 patients per month were randomly assigned. All patients completed the 90-day follow up.&lt;h4>Conclusion&lt;/h4>In our pilot trial, we found that accelerated cholecystectomy was achievable. These results show the feasibility of a trial comparing accelerated and standard care among patients requiring surgery for acute cholecystitis and support a definitive trial.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov, no. NCT04033822.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar-Apr</publication><modification>2026-06-01T17:56:36.809Z</modification><creation>2025-06-26T03:06:08.556Z</creation></dates><accession>S-EPMC11999720</accession><cross_references><pubmed>40216437</pubmed><doi>10.1503/cjs.016423</doi></cross_references></HashMap>